Valuation Northeast Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 30/10/2026			5-day change	1st Jan Change
4.340 ^CNY	+0.23%		-3.34%	-16.86%

29/10	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
25/08	Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	6,848	8,384	9,051	7,646	7,531	7,449
Change	-	22.43%	7.95%	-15.52%	-1.5%	-1.09%
Enterprise Value (EV) ¹	7,967	8,322	7,403	4,178	4,656	5,959
Change	-	4.45%	-11.04%	-43.57%	11.44%	27.99%
P/E	507x	88.9x	25.2x	21.4x	18.2x	29x
PBR	1.72x	2.02x	1.99x	1.53x	1.42x	1.35x
PEG	-	0x	0x	-	1.1x	-0.8x
Capitalization / Revenue	0.93x	1.03x	1.03x	0.93x	1x	1.05x
EV / Revenue	1.08x	1.02x	0.84x	0.51x	0.62x	0.84x
EV / EBITDA	11.6x	11.6x	9.9x	4.62x	4.57x	7.76x
EV / EBIT	37.3x	39.5x	33.7x	11.4x	9.78x	23.1x
EV / FCF	21.7x	6.29x	6.2x	2.52x	-20.7x	-4.81x
FCF Yield	4.6%	15.9%	16.1%	39.7%	-4.84%	-20.8%
Dividend per Share ²	0.008	0.014	0.1	0.1	0.1	0.055
Rate of return	0.16%	0.23%	1.58%	1.87%	1.9%	1.05%
EPS ²	0.01	0.07	0.25	0.25	0.29	0.18
Distribution rate	80%	20%	40%	40%	34.5%	30.6%
Net sales ¹	7,384	8,145	8,809	8,243	7,503	7,075
EBITDA ¹	688.6	715.8	747.7	904.6	1,019	767.9
EBIT ¹	213.6	210.6	219.6	366.2	476	258.2
Net income ¹	12.26	99.03	350.1	358.5	409.8	260.1
Net Debt ¹	1,119	-62.17	-1,647	-3,468	-2,876	-1,491
Reference price ²	5.070	6.220	6.310	5.350	5.270	5.220
Nbr of stocks (in thousands)	1,350,702	1,347,873	1,434,316	1,429,103	1,429,103	1,427,088
Announcement Date	16/3/21	30/3/22	29/3/23	29/3/24	2/4/25	2/4/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NORTHEAST PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	927M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.78B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%